Other Income & Expense
Other Income (Expense)
Gilead Sciences Other Income (Expense) decreased by 32.7% to $235.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 171.6%, from -$328.00M to $235.00M. Over 3 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a 4.7% CAGR.
Analysis
StatementIncome Statement
SectionOther Income & Expense
CategoryProfitability
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 7, 2026
How to read this metric
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Detailed definition
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Peer comparison
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
Metric ID:
other_income_expense_netHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$173.00M | -$154.00M | $0.00 | -$111.00M | -$284.00M | -$176.00M | -$10.00M | -$174.00M | $152.00M | -$72.00M | $293.00M | $91.00M | -$355.00M | $306.00M | -$328.00M | $208.00M | $569.00M | $349.00M | $235.00M |
| QoQ Change | — | +11.0% | +100.0% | — | -155.9% | +38.0% | +94.3% | <-999% | +187.4% | -147.4% | +506.9% | -68.9% | -490.1% | +186.2% | -207.2% | +163.4% | +173.6% | -38.7% | -32.7% |
| YoY Change | — | — | — | — | -64.2% | -14.3% | — | -56.8% | +153.5% | +59.1% | >999% | +152.3% | -333.6% | +525.0% | -460.4% | +158.6% | +85.9% | — | +171.6% |
Range-$355.00M – $569.00M
CAGR+7.0%
Avg YoY Growth+262.1%
Median YoY Growth+85.9%
Current Streak2 quarters decline
Other Income (Expense) at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's other income (expense)?
- Gilead Sciences (GILD) reported other income (expense) of $235.00M in Q1 2026.
- How has Gilead Sciences's other income (expense) changed year-over-year?
- Gilead Sciences's other income (expense) increased by 171.6% year-over-year, from -$328.00M to $235.00M.
- What is the long-term trend for Gilead Sciences's other income (expense)?
- Over 3 years (2021 to 2025), Gilead Sciences's other income (expense) has grown at a 4.7% compound annual growth rate (CAGR), from -$696.00M to $798.00M.
- What does other income (expense) mean?
- The net result of all income and expenses not related to core business operations.